Organization: Health Canada
Year: 2020
Month: January
Request Number: A-2019-001020
Request Summary: Module 1 and 2 contained in the Abbreviated New Drug Submission (ANDS) that is under review with Health Canada as at September 27, 2019 for a subsequent entry product containing the medicinal ingredient cladribine.
Disposition: Disclosed in part
Number of pages: 2